PosterPDF Available

MC1306. Rescue With High Frequency Oscillatory Ventilation In A 22-Year-Old Fetal Demise Patient With Severe Refractory Hypoxemia

Authors:

Abstract

We report the case of a 22-year-old pregnant female who initially presented with refractory hypotension and hypoxemia secondary to urosepsis and pulmonary edema. Conventional methods of non-invasive ventilation (NIV) and mechanical ventilation were unsuccessful in improving the patient's condition. High-frequency oscillatory ventilation (HFOV) was intitiated on the patient as an acute treatment. This case provides valuable insight for the use of HFOV in patients who are failing conventional mechanical ventilation despite maximal manipulation of the variables which support oxygenation.
INTRODUCTION
Case Report
Case Report CONCLUSIONS
CLINICAL IMPLICATIONS
REFERENCES
Rescue with High Frequency Oscillatory Ventilation in a 22-Year-Old Female
High frequency oscillatory ventilation (HFOV) is a form
of lung-protective ventilation with limited evidence for
use in the adult population. Despite this lack of data,
HFOV remains a viable option as a rescue therapy for
severe refractory hypoxemia after other modalities of
ventilation have failed.
We report the case of a 22-year-old pregnant female
who initially presented from an outside hospital with
nausea, emesis and fatigue. Her symptoms progressed
to refractory hypotension and hypoxemia secondary to
urosepsis and pulmonary edema. The patient remained
hypoxemic during a trial of non-invasive ventilation
(NIV). She was subsequently intubated and placed on
conventional mechanical ventilation using pressure
regulated volume control (PRVC). The patient
continued to deteriorate leading to cardiopulmonary
arrest. Multiple rounds of epinephrine and CPR were
required before achieving ROSC. The patient was not a
viable candidate for ECMO therapy per CT surgery.
Discussions with the family were prompted by the
attending physician and hospital chaplain surrounding
the grave prognosis of the patient. Post arrest, arterial
blood gas (ABG) values of pH 7.26, PaCO2 44, PaO2 40,
HCO3- 19.7, BE -7.0, SaO2 67.4% were obtained on
PRVC with settings of Vt 350 mL, RR 25
breaths/minute, PEEP 20 cmH2O, FiO2 100%, and I:E
ratio 2:1.
HFOV was initiated as a rescue therapy. Initial HFOV settings were MAP
33 cmH2O, 4 Hz, Power 9, bias flow 25 l/min, I-time 33%, and FiO2
100%. One hour post HFOV initiation, PaO2 51mmHg with SaO2 87.8%.
After 3 hours on the oscillator, ABG revealed pH 7.54, PaCO2 24.7, PaO2
190, HCO3- 20.6, BE -1.1, SaO2 99%. Weaning down to minimal
oscillator settings occurred twenty-two hours post HFOV initiation.
Transition back to conventional mechanical ventilation was successful
after 29 total hours on the oscillator. Subsequently, the patient was
extubated to a nasal cannula, appropriate and following commands.
HFOV is an effective rescue therapy for severely
hypoxemic respiratory failure patients who are failing
conventional ventilation. HFOV can effectively deliver a
substantial mean airway pressure, improve ventilation-
perfusion matching, and increase oxygenation. Patient
selection and clinician expertise remain key variables
impacting HFOV outcomes.
1. Derdak S, Mehta S, Stewart TE, Smith T, Rogers M, Buchman TG,
Carlin B, Lowson S, Granton J: The Multicenter Oscillatory
Ventilation for Acute Respiratory Distress Syndrome Trial (MOAT)
study investigators: high-frequency oscillatory ventilation for acute
respiratory distress syndrome in adults: a randomized, controlled
trial. Am J Respir Crit Care Med. 2002, 166: 801-808.
10.1164/rccm.2108052.
2. Nguyen AP, Schmidt UH, MacIntyre NR. Should High-Frequency
Ventilation in the Adult Be Abandoned?. Respir Care.
2016;61(6):791-800. doi:10.4187/respcare.04584
Herrington, Ramona RRT (1) , Weaver, Chaston RRT (1) , Ford, Leslie MS, RRT (2) , Kumar, Vikas MD (3)
1. Respiratory Care Department, Augusta University Medical Center, Augusta, Georgia
2. Respiratory Therapy Program, Augusta University, Augusta, Georgia
3. Department of Anesthesiology and Perioperative Medicine, Augusta University, Augusta, Georgia
This case provides valuable insight for the use of HFOV
in patients who are failing conventional mechanical
ventilation despite maximal manipulation of the
variables which support oxygenation. In patients who
are ineligible for ECMO therapy, HFOV is a viable rescue
therapy. This case also compliments a multidisciplinary
teamwork approach involved in the critical care of an
antepartum patient.
Pre HFOV Post HFOV
ResearchGate has not been able to resolve any citations for this publication.
Article
Full-text available
Observational studies of high-frequency oscillatory ventilation in adults with the acute respiratory distress syndrome have demonstrated improvements in oxygenation. We designed a multicenter, randomized, controlled trial comparing the safety and effectiveness of high-frequency oscillatory ventilation with conventional ventilation in adults with acute respiratory distress syndrome; 148 adults with acute respiratory distress syndrome (Pa(O2)/fraction of inspired oxygen <or= 200 mm Hg on 10 or more cm H2O positive end-expiratory pressure) were randomized to high-frequency oscillatory ventilation (n = 75) or conventional ventilation (n = 73). Applied mean airway pressure was significantly higher in the high-frequency oscillation group compared with the conventional ventilation group throughout the first 72 hours (p = 0.0001). The high-frequency oscillation group showed early (less than 16 hours) improvement in Pa(O2)/fraction of inspired oxygen compared with the conventional ventilation group (p = 0.008); however, this difference did not persist beyond 24 hours. Oxygenation index decreased similarly over the first 72 hours in both groups. Thirty-day mortality was 37% in the high-frequency oscillation group and was 52% in the conventional ventilation group (p = 0.102). The percentage of patients alive without mechanical ventilation at Day 30 was 36% and 31% in the high-frequency oscillation and conventional ventilation groups, respectively (p = 0.686). There were no significant differences in hemodynamic variables, oxygenation failure, ventilation failure, barotraumas, or mucus plugging between treatment groups. We conclude that high-frequency oscillation is a safe and effective mode of ventilation for the treatment of acute respiratory distress syndrome in adults.
Article
High-frequency oscillatory ventilation (HFOV) can improve ventilation-perfusion matching without excessive alveolar tidal stretching or collapse-reopening phenomenon. This is an attractive feature in the ventilation of patients with ARDS. However, two recent large multi-center trials of HFOV failed to show benefits in this patient population. The following review addresses whether, in view of these trails, HFOV should be abandoned in the adult population?.